Circular RNAs (circRNAs) are non-coding RNA molecules that play a crucial role in regulating genes and contributing to disease progression. CircRNAs can function as sponges for microRNAs (miRNAs), thereby regulating gene expression and influencing disease outcomes. Identifying associations between circRNAs and miRNAs through computational methods enhances the understanding of complex disease mechanisms and offers a reliable tool for pre-selecting candidates for experimental validation. Existing models, however, are limited in their ability to capture either global or local node information, the prediction of circRNA and miRNA interactions is still challenging. In order to effectively deal with this problem, we propose a novel framework for predicting circRNA-miRNA interactions (CMIs), known as MuGNet-CMI, which leverages multi-head hybrid graph neural network and global high-order and local low-order information. The model employs the MetaPath2Vec algorithm to generate high-quality node embeddings within the circRNA-miRNA heterogeneous matrix. The multi-head dynamic attention mechanism, combined with GraphSAGE, is incorporated to efficiently capture both global high-order and local low-order node information. Additionally, we integrate neural aggregators into the multi-head dynamic attention mechanism to aggregate feature information from the captured nodes. Validation using three real datasets demonstrates that MuGNet-CMI delivers good performance in predicting CMIs, offering valuable insights to guide experimental research in gene regulation.

Competitive endogenous RNA (ceRNA) networks are pivotal for uncovering disease molecular mechanisms. Graph representation learning is a cornerstone for modeling biological regulatory networks and predicting disease-related biomarkers. However, current methods face challenges: traditional graph neural network (GNN) rely on low-order graph structures, which struggle to capture high-order molecular interactions, resulting in topological information loss; shallow GNN fail to model long-range dependencies, while deep architectures suffer from over-smoothing, limiting complex regulatory expression; static embeddings overlook dynamic molecular interactions, reducing biomarker accuracy. These limitations highlight the need for advanced graph learning frameworks. To address these challenges, we propose DMHLF, a Dynamic Multi-scale Hypergraph Learning Framework for predicting disease-associated ceRNA biomarkers. The framework first integrates multiple regulatory relationships among miRNAs, lncRNAs, circRNAs, mRNAs, and diseases to construct disease-specific ceRNA regulatory networks, capturing local and global regulatory patterns through multi-Hop hyperedges. Subsequently, we devise a Hypergraph-Weighted Dynamic Random Walk (HEDRW) method to dynamically extract node meta-embeddings that encode high-order regulatory information. Concurrently, we extend Eigen-GNN spectral analysis to hypergraph structures, incorporating a residual-enhanced hypergraph neural network to preserve the global topological properties of shallow hypergraphs. Finally, a cross-scale attention mechanism aligns and fuses multi-scale features to generate high-quality node embeddings for disease-ceRNA association prediction. Experiments on diverse datasets demonstrate that DMHLF significantly outperforms existing methods. Case study further validates the framework's efficacy in identifying disease-related ceRNA biomarkers, providing a reliable predictive tool for biomedical research.

Magnetic resonance imaging (MRI) data segmentation plays a critical role in clinical diagnosis and treatment planning. However, the performance of deep learning-based segmentation models is often hindered by domain shifts caused by variations in imaging factors. To address this challenge, we propose GSAM-MRI, a Generalized Segment Anything Model for robust MRI segmentation in the scenario of single-source domain generalization (SDG). GSAM-MRI integrates multiple components to enhance domain generalization: (1) Frequency-based Domain Randomization module that simulates inter-site variability by perturbing the frequency domain; (2) Domain Adversarial Block that promotes domain-invariant feature learning through adversarial training; (3) General Embedding Generator that fuses multi-scale hierarchical features to produce dense prompt embeddings; Additionally, a hybrid loss function is employed for output consistency. Experiments on prostate segmentation and white matter hyperintensity segmentation tasks demonstrate that GSAM-MRI consistently outperforms state-of-the-art SDG methods and baseline models, achieving superior generalization across unseen domains.

Accurate prediction of circRNA-disease associations (CDAs) is essential for elucidating disease mechanisms and identifying potential biomarkers. However, existing computational methods often struggle to fully capture multi-scale topological patterns and molecular attribute information within biological networks. To address this, we introduce MuseCDA, a novel framework designed to predict CDAs via multi-scale structure embedding. MuseCDA first leverages bidirectional transformer to generate bio-semantics from circRNA sequences, while incorporating disease similarities based on Gaussian kernel distance. It then employs random walks to capture both local neighborhood structures and global high-order network patterns, enabling comprehensive modeling of biological relationships across hierarchical levels. Finally, MuseCDA utilizes a multilayer perceptron to predict association scores. Through the seamless integration of sequence bio-semantics, Gaussian similarities, and multiscale structural features, MuseCDA achieves highly accurate CDA predictions. Evaluated on the CircR2Disease 2.0 dataset, MuseCDA demonstrates superior performance with an AUC of 0.9147, significantly surpassing baseline methods. Case studies further confirm its capability to identify novel candidates, offering valuable insights for biomarker discovery and the exploration of regulatory networks.

MOTIVATION: Research shows that competing endogenous RNA is widely involved in gene regulation in cells, and identifying the association between circular RNA (circRNA), microRNA (miRNA), and cancer can provide new hope for disease diagnosis, treatment, and prognosis. However, affected by reductionism, previous studies regarded the prediction of circRNA-miRNA interaction, circRNA-cancer association, and miRNA-cancer association as separate studies. Currently, few models are capable of simultaneously predicting these three associations. RESULTS: Inspired by holism, we propose a multi-task prediction method based on neighborhood structure embedding and signed graph representation learning, CMCSG, to infer the relationship between circRNA, miRNA, and cancer. Our method aims to extract feature descriptors of all molecules from the circRNA-miRNA-cancer regulatory network using known types of association information to predict unknown types of molecular associations. Specifically, we first constructed the circRNA-miRNA-cancer association network (CMCN), which is constructed based on the experimentally verified biomedical entity regulatory network; next, we combine topological structure embedding methods to extract feature representations in CMCN from local and global perspectives, and use denoising autoencoder for enhancement; then, combined with balance theory and state theory, molecular features are extracted from the point of social relations through the propagation and aggregation of signed graph attention network; finally, the GBDT classifier is used to predict the association of molecules. The results show that CMCSG can effectively predict the relationship between circRNA, miRNA, and cancer. Additionally, the case studies also demonstrate that CMCSG is capable of accurately identifying biomarkers across various types of cancer. The data and source code can be found at https://github.com/1axin/CMCSG.

The discovery of diagnostic and therapeutic biomarkers for complex diseases, especially cancer, has always been a central and long-term challenge in molecular association prediction research, offering promising avenues for advancing the understanding of complex diseases. To this end, researchers have developed various network-based prediction techniques targeting specific molecular associations. However, limitations imposed by reductionism and network representation learning have led existing studies to narrowly focus on high prediction efficiency within single association type, thereby glossing over the discovery of unknown types of associations. Additionally, effectively utilizing network structure to fit the interaction properties of regulatory networks and combining specific case biomarker validations remains an unresolved issue in cancer biomarker prediction methods. To overcome these limitations, we propose a multi-view learning framework, CeRVE, based on directed graph neural networks (DGNN) for predicting unknown type cancer biomarkers. CeRVE effectively extracts and integrates subgraph information through multi-view feature learning. Subsequently, CeRVE utilizes DGNN to simulate the entire regulatory network, propagating node attribute features and extracting various interaction relationships between molecules. Furthermore, CeRVE constructed a comparative analysis matrix of three cancers and adjacent normal tissues through The Cancer Genome Atlas and identified multiple types of potential cancer biomarkers through differential expression analysis of mRNA, microRNA, and long noncoding RNA. Computational testing of multiple types of biomarkers for 72 cancers demonstrates that CeRVE exhibits superior performance in cancer biomarker prediction, providing a powerful tool and insightful approach for AI-assisted disease biomarker discovery.

Identifying potential cancer biomarkers is a key task in biomedical research, providing a promising avenue for the diagnosis and treatment of human tumors and cancers. In recent years, several machine learning-based RNA-disease association prediction techniques have emerged. However, they primarily focus on modeling relationships of a single type, overlooking the importance of gaining insights into molecular behaviors from a complete regulatory network perspective and discovering biomarkers of unknown types. Furthermore, effectively handling local and global topological structural information of nodes in biological molecular regulatory graphs remains a challenge to improving biomarker prediction performance. To address these limitations, we propose a multichannel graph neural network based on multisimilarity modality hypergraph contrastive learning (MML-MGNN) for predicting unknown types of cancer biomarkers. MML-MGNN leverages multisimilarity modality hypergraph contrastive learning to delve into local associations in the regulatory network, learning diverse insights into the topological structures of multiple types of similarities, and then globally modeling the multisimilarity modalities through a multichannel graph autoencoder. By combining representations obtained from local-level associations and global-level regulatory graphs, MML-MGNN can acquire molecular feature descriptors benefiting from multitype association properties and the complete regulatory network. Experimental results on predicting three different types of cancer biomarkers demonstrate the outstanding performance of MML-MGNN. Furthermore, a case study on gastric cancer underscores the outstanding ability of MML-MGNN to gain deeper insights into molecular mechanisms in regulatory networks and prominent potential in cancer biomarker prediction.

According to the expression of miRNA in pathological processes, miRNAs can be divided into oncogenes or tumor suppressors. Prediction of the regulation relations between miRNAs and small molecules (SMs) becomes a vital goal for miRNA-target therapy. But traditional biological approaches are laborious and expensive. Thus, there is an urgent need to develop a computational model. In this study, we proposed a computational model to predict whether the regulatory relationship between miRNAs and SMs is up-regulated or down-regulated. Specifically, we first use the Large-scale Information Network Embedding (LINE) algorithm to construct the node features from the self-similarity networks, then use the General Attributed Multiplex Heterogeneous Network Embedding (GATNE) algorithm to extract the topological information from the attribute network, and finally utilize the Light Gradient Boosting Machine (LightGBM) algorithm to predict the regulatory relationship between miRNAs and SMs. In the fivefold cross-validation experiment, the average accuracies of the proposed model on the SM2miR dataset reached 79.59% and 80.37% for up-regulation pairs and down-regulation pairs, respectively. In addition, we compared our model with another published model. Moreover, in the case study for 5-FU, 7 of 10 candidate miRNAs are confirmed by related literature. Therefore, we believe that our model can promote the research of miRNA-targeted therapy.

Circular RNA (CircRNA)-microRNA (miRNA) interaction (CMI) is an important model for the regulation of biological processes by non-coding RNA (ncRNA), which provides a new perspective for the study of human complex diseases. However, the existing CMI prediction models mainly rely on the nearest neighbor structure in the biological network, ignoring the molecular network topology, so it is difficult to improve the prediction performance. In this paper, we proposed a new CMI prediction method, BEROLECMI, which uses molecular sequence attributes, molecular self-similarity, and biological network topology to define the specific role feature representation for molecules to infer the new CMI. BEROLECMI effectively makes up for the lack of network topology in the CMI prediction model and achieves the highest prediction performance in three commonly used data sets. In the case study, 14 of the 15 pairs of unknown CMIs were correctly predicted.

MOTIVATION: A large number of studies have shown that circular RNA (circRNA) affects biological processes by competitively binding miRNA, providing a new perspective for the diagnosis, and treatment of human diseases. Therefore, exploring the potential circRNA-miRNA interactions (CMIs) is an important and urgent task at present. Although some computational methods have been tried, their performance is limited by the incompleteness of feature extraction in sparse networks and the low computational efficiency of lengthy data. RESULTS: In this paper, we proposed JSNDCMI, which combines the multi-structure feature extraction framework and Denoising Autoencoder (DAE) to meet the challenge of CMI prediction in sparse networks. In detail, JSNDCMI integrates functional similarity and local topological structure similarity in the CMI network through the multi-structure feature extraction framework, then forces the neural network to learn the robust representation of features through DAE and finally uses the Gradient Boosting Decision Tree classifier to predict the potential CMIs. JSNDCMI produces the best performance in the 5-fold cross-validation of all data sets. In the case study, seven of the top 10 CMIs with the highest score were verified in PubMed. AVAILABILITY: The data and source code can be found at https://github.com/1axin/JSNDCMI.